Neuren Pharmaceuticals Statistics
Total Valuation
ASX:NEU has a market cap or net worth of AUD 1.52 billion. The enterprise value is 1.22 billion.
| Market Cap | 1.52B |
| Enterprise Value | 1.22B |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:NEU has 126.64 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 126.64M |
| Shares Outstanding | 126.64M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +2.76% |
| Owned by Insiders (%) | 3.91% |
| Owned by Institutions (%) | 23.88% |
| Float | 109.27M |
Valuation Ratios
The trailing PE ratio is 51.57 and the forward PE ratio is 93.87.
| PE Ratio | 51.57 |
| Forward PE | 93.87 |
| PS Ratio | 23.51 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 4.49 |
| P/FCF Ratio | 12.12 |
| P/OCF Ratio | 12.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 55.46, with an EV/FCF ratio of 9.76.
| EV / Earnings | 40.20 |
| EV / Sales | 18.93 |
| EV / EBITDA | 55.46 |
| EV / EBIT | 55.52 |
| EV / FCF | 9.76 |
Financial Position
The company has a current ratio of 76.60
| Current Ratio | 76.60 |
| Quick Ratio | 74.40 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.67% and return on invested capital (ROIC) is 40.70%.
| Return on Equity (ROE) | 8.67% |
| Return on Assets (ROA) | 3.66% |
| Return on Invested Capital (ROIC) | 40.70% |
| Return on Capital Employed (ROCE) | 6.51% |
| Weighted Average Cost of Capital (WACC) | 13.80% |
| Revenue Per Employee | 8.08M |
| Profits Per Employee | 3.80M |
| Employee Count | 8 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ASX:NEU has paid 8.49 million in taxes.
| Income Tax | 8.49M |
| Effective Tax Rate | 21.82% |
Stock Price Statistics
The stock price has decreased by -9.16% in the last 52 weeks. The beta is 1.61, so ASX:NEU's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -9.16% |
| 50-Day Moving Average | 16.30 |
| 200-Day Moving Average | 17.30 |
| Relative Strength Index (RSI) | 33.71 |
| Average Volume (20 Days) | 565,245 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:NEU had revenue of AUD 64.65 million and earned 30.44 million in profits. Earnings per share was 0.23.
| Revenue | 64.65M |
| Gross Profit | 28.26M |
| Operating Income | 22.04M |
| Pretax Income | 38.93M |
| Net Income | 30.44M |
| EBITDA | 22.06M |
| EBIT | 22.04M |
| Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has 296.12 million in cash and n/a in debt, giving a net cash position of 296.12 million or 2.34 per share.
| Cash & Cash Equivalents | 296.12M |
| Total Debt | n/a |
| Net Cash | 296.12M |
| Net Cash Per Share | 2.34 |
| Equity (Book Value) | 338.45M |
| Book Value Per Share | 2.67 |
| Working Capital | 327.90M |
Cash Flow
In the last 12 months, operating cash flow was 125.42 million and capital expenditures -37,000, giving a free cash flow of 125.39 million.
| Operating Cash Flow | 125.42M |
| Capital Expenditures | -37,000 |
| Free Cash Flow | 125.39M |
| FCF Per Share | 0.99 |
Margins
Gross margin is 43.71%, with operating and profit margins of 34.09% and 47.08%.
| Gross Margin | 43.71% |
| Operating Margin | 34.09% |
| Pretax Margin | 60.22% |
| Profit Margin | 47.08% |
| EBITDA Margin | 34.13% |
| EBIT Margin | 34.09% |
| FCF Margin | 193.95% |
Dividends & Yields
ASX:NEU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.01% |
| Earnings Yield | 2.00% |
| FCF Yield | 8.25% |
Stock Splits
The last stock split was on November 21, 2017. It was a reverse split with a ratio of 0.05.
| Last Split Date | Nov 21, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
ASX:NEU has an Altman Z-Score of 271.81 and a Piotroski F-Score of 5.
| Altman Z-Score | 271.81 |
| Piotroski F-Score | 5 |